Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Oncoceutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.


$5.2 M

FY, 2019

CreditSafe Score

Score changed on Dec 11, 2023
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2018FY, 2019
General and administrative expense1.5M2.4M
Operating expense total5.6M9.1M
EBIT margin, %-213.4%-75.5%
Interest income55.0K195.6K
Net Income(3.7M)(3.7M)

Footer menu